Journal article
Stem cell therapy for Alport syndrome: The hope beyond the hype
O Gross, DB Borza, HJ Anders, C Licht, M Weber, S Segerer, R Torra, MC Gubler, L Heidet, S Harvey, D Cosgrove, G Lees, C Kashtan, M Gregory, J Savige, J Ding, P Thorner, DR Abrahamson, C Antignac, K Tryggvason Show all
Nephrology Dialysis Transplantation | OXFORD UNIV PRESS | Published : 2009
DOI: 10.1093/ndt/gfn722
Grants
Awarded by National Institute of Diabetes and Digestive and Kidney Diseases
Funding Acknowledgements
C. K. is the executive director of the Alport Syndrome Treatments and Outcomes Registry (ASTOR), USA. O.G. is the principal investigator of the European Alport therapy registry, supported by the Association pour l'Information et la Recherche sur les maladies renale Genetiques France and the KfH-Foundation Preventive Medicine.